This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The stress of heart failure is remembered by the body and appears to lead to recurrent failure, along with other related health issues, according to new research. Researchers have found that heart failure leaves a 'stress memory' in the form of changes to the DNA modification of hematopoietic stem cells, which are involved in the production of blood and immune cells called macrophages.
(MedPage Today) -- For people with type 2 diabetes and chronic kidney disease (CKD), semaglutide (Ozempic) reduced the risk of major kidney events and death from cardiovascular causes, the phase III FLOW trial showed. Added to usual care, the.
Semaglutide 1.0 mg reduced major kidney disease events and slowed eGFR decline in patients with type 2 diabetes and chronic kidney disease, according to the FLOW trial.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. This is not good. Why? Because a diagnosis of diabetes is very likely to shorten your life. A diagnosis of type 2 diabetes at age 30 can result in a 14 to 16-year shorter lifespan 2.
The Patient: A 78-year-old woman called emergency responders because she had palpitations. She was alert and oriented. Her BP was reported as being “stable”. We do not have information about her past medical history. We will update this post if we receive information about her outcome. ECG Number 1, 11:57 a.m.: There is a wide-complex tachycardia at a rate of about 230 bpm.
As we near the end of National Women’s Health Awareness Month, at CMHC , we want to bring attention to the important discussion of continuous glucose monitoring (CGM) during pregnancy and across the lifespan. CGM offers continuous, real-time glucose readings around the clock, surpassing traditional methods like HbA1C measurements and blood finger sticks.
As we near the end of National Women’s Health Awareness Month, at CMHC , we want to bring attention to the important discussion of continuous glucose monitoring (CGM) during pregnancy and across the lifespan. CGM offers continuous, real-time glucose readings around the clock, surpassing traditional methods like HbA1C measurements and blood finger sticks.
(MedPage Today) -- Note that some links may require registration or subscription. Also note that in observance of the Memorial Day holiday, our Morning Break feature will not appear on Monday. Look for its return on Tuesday, May 28. U.S. Representative.
What is the relationship between aortic valve calcification (AVC) and aortic stenosis (AS) severity in patients with suspected low-flow low-gradient AS?
(MedPage Today) -- An FDA advisory committee mostly agreed on Friday that an investigational once-weekly insulin product carries too much risk for use in adult patients with type 1 diabetes to recommend approval in this patient population. In.
What is the prognostic value of microvascular resistance reserve (MRR) in patients with ST-segment elevation myocardial infarction (STEMI), and how does MRR compare with cardiac magnetic resonance (CMR) imaging parameters of microvascular resistance?
1) Nicola A. Hanania, MD, MS, discusses what we have learned from asthma research on the involvement of type 2 inflammation that is applicable to COPD.
The goal of the FIRE trial was to evaluate multivessel revascularization guided by coronary physiology compared with culprit-only revascularization among elderly patients with acute myocardial infarction (MI) and multivessel coronary artery disease (CAD).
Igor Barjaktarevic, MD, PhD, provides insights on the evolving role of biomarkers in COPD, highlighting the role of eosinophils on informing treatment decisions.
In this episode, Andrea Price, MS, AACC hosts Jill Steiner, MD, MS, FACC, and Rosy Thachil, MD, FACC for a discussion on the importance of social support and its role in promoting good mental health, especially among people with a chronic illness like heart disease.
milla1cf Fri, 05/24/2024 - 07:00 May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their Cedars-Sinai colleagues can detect a type of abnormal heart rhythm that can go unnoticed during medical appointments, according to a new study. The study’s findings, published in npj Digital Medicine , suggest AI could one day be employed to analyze images from a common imaging test called an echocardiogram, which uses sound waves to captur
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Greetings! Welcome to the Physiology Friday newsletter. Details about the sponsors of this newsletter including Examine.com and my book “VO2 Max Essentials ” can be found at the end of the post! Physiologically Speaking is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Is a novel modular pacing–defibrillator system, consisting of a leadless pacemaker in wireless communication with a subcutaneous implantable cardioverter–defibrillator (ICD), able to effectively and safely provide antitachycardia and bradycardia pacing?
The goal of the RENOVATE-COMPLEX-PCI trial was to evaluate intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography-guided PCI among patients with complex coronary artery disease.
Publication date: Available online 23 May 2024 Source: The American Journal of Cardiology Author(s): Sina Kazemian, Kannu Bansal, Toshiki Kuno, Tanush Gupta, Kashish Goel, Sahil Khera, Mohamad Alkhouli, Dhaval Kolte
Designed to give healthcare professionals an understanding of the epidemiology and pathophysiology of heart failure (HF). It is one of several modules in our heart failure programme.
Introduction The aims of chronic heart failure (HF) management are: to provide symptom relief to prevent hospitalisation for HF to improve survival. Optimal pharmacological and non-pharmacological management (including device treatment) have had an enormous beneficial impact on the clinical course of HF. This module will focus on lifestyle modifications and pharmacological treatment.
Designed to give healthcare professionals an understanding of other methods of managing heart failure, it is one of several modules in our heart failure programme.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content